Marvin Slosman
CIK: 0001796908
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 6, 2026BCDA
BioCardia, Inc.
Award(A)DirectStock Option (right to buy)
8K shares- - May 12, 2026NSPR
InspireMD, Inc.
Purchase(P)Direct21K shares at avg. $1.20$25K - Jan 14, 2026NSPR
InspireMD, Inc.
Award(A)Direct1.1M shares- - Dec 8, 2025BCDA
BioCardia, Inc.
Award(A)DirectStock Option (right to buy)
12K shares- - Jul 30, 2025NSPR
InspireMD, Inc.
Purchase(P)Direct10.3K shares at avg. $2.42$25K - Jan 7, 2025NSPR
InspireMD, Inc.
Award(A)Direct558.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 6, 2026 |  BCDA BioCardia, Inc. | Award(A) Stock Option (right to buy) | 8,000 | - | - | Direct |
| May 12, 2026 |  NSPR InspireMD, Inc. | Purchase(P) | 21,000 | $1.20 | $25,200 | Direct |
| Jan 14, 2026 | NSPR InspireMD, Inc. | Award(A) | 1,114,792 | - | $0 | Direct |
| Dec 8, 2025 | BCDA BioCardia, Inc. | Award(A) Stock Option (right to buy) | 12,000 | - | - | Direct |
| Jul 30, 2025 | NSPR InspireMD, Inc. | Purchase(P) | 10,330 | $2.42 | $24,999 | Direct |
| Jan 7, 2025 | NSPR InspireMD, Inc. | Award(A) | 558,417 | - | $0 | Direct |
1-6 of 6 transactions
About Slosman Marvin
Slosman Marvin (SEC CIK 0001796908) files insider reports with the SEC as Director of BioCardia, Inc. (BCDA) and CEO and President of InspireMD, Inc. (NSPR).
Signal8 holds 7 ownership filings by Slosman Marvin (1 Form 3, 6 Form 4), filed between Jan 10, 2025 and Jul 7, 2026. Those filings report 6 transactions, from Jan 7, 2025 to Jul 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Slosman Marvin's filings is in SUNNYVALE, CA.
Recent filings by Slosman Marvin
- Jul 6, 2026: Grant or award of BCDA derivative securities (Form 4, code A).
- May 12, 2026: Open-market purchase of NSPR shares (Form 4, code P).
- Jan 14, 2026: Grant or award of NSPR shares (Form 4, code A).
- Dec 8, 2025: Grant or award of BCDA derivative securities (Form 4, code A).
- Jul 30, 2025: Open-market purchase of NSPR shares (Form 4, code P).
Other insiders filing for BioCardia, Inc. (BCDA)
- Altman Peter, President and CEO
- STERTZER SIMON H, Director
- McClung David, Chief Financial Officer
- GILLIS EDWARD M, Senior Vice President, Devices
- Blank Andrew Scott, Director
- Allen Jim L., Director